Mikiko Suzuki

3.1k total citations
73 papers, 2.3k citations indexed

About

Mikiko Suzuki is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mikiko Suzuki has authored 73 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 11 papers in Genetics and 10 papers in Hematology. Recurrent topics in Mikiko Suzuki's work include Genomics, phytochemicals, and oxidative stress (17 papers), Epigenetics and DNA Methylation (16 papers) and Hemoglobinopathies and Related Disorders (11 papers). Mikiko Suzuki is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (17 papers), Epigenetics and DNA Methylation (16 papers) and Hemoglobinopathies and Related Disorders (11 papers). Mikiko Suzuki collaborates with scholars based in Japan, United States and United Kingdom. Mikiko Suzuki's co-authors include Masayuki Yamamoto, Akihito Otsuki, Nadine Keleku-Lukwete, James Douglas Engel, Kinuko Ohneda, Takashi Moriguchi, Fumiki Katsuoka, Shosei Yoshida, Kouhei Tsuchida and Kenshiro Hara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mikiko Suzuki

72 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikiko Suzuki Japan 26 1.4k 363 292 247 212 73 2.3k
Haiyu Zhang China 30 1.5k 1.1× 215 0.6× 470 1.6× 233 0.9× 126 0.6× 90 2.9k
Patrick B. Walter United States 21 1.1k 0.8× 647 1.8× 515 1.8× 188 0.8× 100 0.5× 50 2.7k
Gur P. Kaushal United States 36 1.6k 1.1× 172 0.5× 140 0.5× 177 0.7× 106 0.5× 56 3.6k
Ying Huang China 29 1.5k 1.1× 342 0.9× 76 0.3× 143 0.6× 205 1.0× 124 2.5k
Lorenza Tacchini Italy 28 1.3k 0.9× 586 1.6× 282 1.0× 163 0.7× 152 0.7× 74 2.8k
Jiying Sun Japan 21 2.0k 1.4× 151 0.4× 152 0.5× 157 0.6× 119 0.6× 45 2.5k
Francesco Piazza Italy 30 1.2k 0.9× 503 1.4× 631 2.2× 207 0.8× 131 0.6× 123 2.8k
Paul Foster United Kingdom 34 1.0k 0.7× 806 2.2× 315 1.1× 211 0.9× 886 4.2× 101 3.3k
Timothy D. Cummins United States 20 1.6k 1.1× 237 0.7× 189 0.6× 645 2.6× 139 0.7× 36 3.5k
Jeffrey A. Moscow United States 35 1.8k 1.3× 209 0.6× 232 0.8× 450 1.8× 370 1.7× 94 3.6k

Countries citing papers authored by Mikiko Suzuki

Since Specialization
Citations

This map shows the geographic impact of Mikiko Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikiko Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikiko Suzuki more than expected).

Fields of papers citing papers by Mikiko Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikiko Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikiko Suzuki. The network helps show where Mikiko Suzuki may publish in the future.

Co-authorship network of co-authors of Mikiko Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Mikiko Suzuki. A scholar is included among the top collaborators of Mikiko Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikiko Suzuki. Mikiko Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazawa, Taiki, Chizumi Abe, Takahiro Ueno, et al.. (2023). Hypolipidemic and Anti-Inflammatory Effects of Curcuma longa-Derived Bisacurone in High-Fat Diet-Fed Mice. International Journal of Molecular Sciences. 24(11). 9366–9366. 8 indexed citations
2.
Suzuki, Mikiko, Mitsuru Naito, Ritsumi Saito, et al.. (2022). Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity. Free Radical Biology and Medicine. 187. 92–104. 19 indexed citations
3.
Suzuki, Mikiko, Shigehiro Yagishita, Kiyoshi Sugihara, et al.. (2021). Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis. Clinical Cancer Research. 27(14). 3970–3979. 24 indexed citations
4.
Yagishita, Shigehiro, Ken Kato, Mami Takahashi, et al.. (2021). Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library. Cancer Science. 112(6). 2454–2466. 13 indexed citations
5.
Yagishita, Shigehiro, Yoshiharu Hayashi, Mikiko Suzuki, et al.. (2021). Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations. Molecular Cancer Therapeutics. 21(2). 359–370. 6 indexed citations
6.
Waku, Tsuyoshi, Yasuomi Urano, Mikiko Suzuki, et al.. (2021). NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition. iScience. 24(10). 103180–103180. 18 indexed citations
7.
Hayashi, Makiko, et al.. (2020). Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors. Cancer Research. 80(16). 3331–3344. 39 indexed citations
8.
Keleku-Lukwete, Nadine, Mikiko Suzuki, Akihito Otsuki, et al.. (2019). Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice. Blood Advances. 3(8). 1285–1297. 18 indexed citations
9.
Keleku-Lukwete, Nadine, Mikiko Suzuki, & Masayuki Yamamoto. (2017). An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment. Antioxidants and Redox Signaling. 29(17). 1746–1755. 79 indexed citations
10.
Takamochi, Kazuya, Mariko Fukui, Mikiko Suzuki, et al.. (2017). Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System. The Annals of Thoracic Surgery. 104(1). 275–283. 26 indexed citations
11.
Tsuchida, Kouhei, Tadayuki Tsujita, Makiko Hayashi, et al.. (2016). Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radical Biology and Medicine. 103. 236–247. 135 indexed citations
12.
Otsuki, Akihito, Mikiko Suzuki, Fumiki Katsuoka, et al.. (2015). Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection. Free Radical Biology and Medicine. 91. 45–57. 56 indexed citations
13.
Suzuki, Mikiko, Kouya Shiraishi, Akihiko Yoshida, et al.. (2014). HER2 gene mutations in non-small cell lung carcinomas: Concurrence with her2 gene amplification and her2 protein expression and phosphorylation. Lung Cancer. 87(1). 14–22. 58 indexed citations
14.
Hara, Kenshiro, Toshinori Nakagawa, Hideki Enomoto, et al.. (2014). Mouse Spermatogenic Stem Cells Continually Interconvert between Equipotent Singly Isolated and Syncytial States. Cell stem cell. 14(5). 658–672. 219 indexed citations
15.
Suzuki, Mikiko, et al.. (2014). A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression. Cancer Cell. 25(4). 415–427. 162 indexed citations
16.
Suzuki, Mikiko, Masayuki Yamamoto, & James Douglas Engel. (2014). Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the β-Globinopathies. Molecular and Cellular Biology. 34(19). 3560–3569. 55 indexed citations
17.
Suzuki, Mikiko, et al.. (1997). Cerebral Magnetic Resonance T2 High Intensities in End-Stage Renal Disease. Stroke. 28(12). 2528–2531. 21 indexed citations
18.
Ieiri, Tamio, Pascale Cochaux, Héctor M. Targovnik, et al.. (1991). A 3' splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism.. Journal of Clinical Investigation. 88(6). 1901–1905. 131 indexed citations
19.
Suzuki, Mikiko, Tomoaki Hayakawa, Jeffrey P. Shaw, M Rekik, & Shigeaki Harayama. (1991). Primary structure of xylene monooxygenase: similarities to and differences from the alkane hydroxylation system. Journal of Bacteriology. 173(5). 1690–1695. 145 indexed citations
20.
Suzuki, Mikiko, et al.. (1986). [Clinical evaluation of fenbufen in the treatment of postoperative inflammation in oral surgery].. PubMed. 74(1). 30–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026